FIELD: chemistry.
SUBSTANCE: method involves asymmetric reduction of (E)-2-(1,6,7,8-tetrahydro-2H-indeno[5,4-b]furan-8-ylidene)ethyleneamine, catalytic reduction of the obtained product at temperature ranging from 40 to 100°C and pH ranging from 3 to 9, propionylation of the obtained (S)-2-(1,6,7,8-tetrahydro-2H-indeno[5,4-b]furan-8-yl)ethylamine, and then crystallisation from the reaction mixture.
EFFECT: obtaining optically active amine derivatives of high purity with high output and prevention of formation of by-products.
6 cl, 1 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
PREVENTIVE OR THERAPEUTIC AGENT FOR DEPRESSION OR ANXIETY DISORDER | 2006 |
|
RU2413510C2 |
TRICYCLIC COMPOUND AND ITS PHARMACEUTICAL APPLICATION | 2007 |
|
RU2456278C2 |
METHOD FOR PRODUCING DEPHENYLMETHANE DERIVATIVE | 2017 |
|
RU2797392C2 |
METHOD OF PRODUCING DEPHENYLMETHANE DERIVATIVE | 2023 |
|
RU2814846C1 |
METHOD OF PRODUCING TOPOTECAN | 2010 |
|
RU2447076C1 |
ISATINE OR ISATINE OXIME DERIVATIVES, METHOD OF SYNTHESIS OF ISATINE OXIME AND A PHARMACEUTICAL COMPOSITION | 1992 |
|
RU2114827C1 |
C-GLYCOSIDE DERIVATIVES CONTAINING A CONDENSED PHENYL RING, OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, A METHOD OF PRODUCING SUCH AND A PHARMACEUTICAL COMPOSITION CONTAINING SUCH | 2017 |
|
RU2739024C2 |
BICYCLOSUBSTITUTED AZOPYRAZOLONE DERIVATIVES SALTS, METHOD FOR PREPARING AND USING THEM | 2010 |
|
RU2538977C2 |
2,6-SUBSTUTED-4-MONOSUBSTITUTED AMINO-PYRIMIDINES AS PROSTAGLANDIN D2 RECEPTOR ANTAGONISTS | 2005 |
|
RU2417990C2 |
DERIVATIVE OF 4,4-DIFLUORO-1,2,2,4-TETRAHYDRO-5H-1-BENZAZEPINE AND ITS SALT | 2004 |
|
RU2326868C2 |
Authors
Dates
2010-03-27—Published
2005-09-12—Filed